Cyclic dipeptides: From bugs to brain

Trends in Molecular Medicine

Volumn 20, Issue 10, 2014, Pages 551-558

  Bellezza, Ilaria ^a   Peirce, Matthew J ^a   Minelli, Alba ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Diketopiperazines; Neurodegeneration; Neuroinflammation; Neuroprotection; Quorum sensing

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; CYCLO(HIS-PRO); DIPEPTIDE; ORGANIC CATION TRANSPORTER; UNCLASSIFIED DRUG; CYCLOPEPTIDE; HISTIDYL-PROLINE DIKETOPIPERAZINE; PIPERAZINE DERIVATIVE;

DRUG TRANSPORT; GLIA CELL; HUMAN; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; NOTE; QUORUM SENSING; ANIMAL; BACTERIUM; BRAIN; CENTRAL NERVOUS SYSTEM; CHEMISTRY; GLIA; INFLAMMATION; METABOLISM; MICROFLORA; PATHOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BACTERIA; BIOLOGICAL TRANSPORT; BRAIN; CENTRAL NERVOUS SYSTEM; DIPEPTIDES; HUMANS; INFLAMMATION; MICROBIOTA; NEUROGLIA; PEPTIDES, CYCLIC; PIPERAZINES; QUORUM SENSING;

EID: 84908122041     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.08.003     Document Type: Review

References (78)

1. Fuqua C., et al. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu. Rev. Genet. 2001, 35:439-468.
2. Sun J., et al. Is autoinducer-2 a universal signal for interspecies communication: a comparative genomic and phylogenetic analysis of the synthesis and signal transduction pathways. BMC Evol. Biol. 2004, 4:36.
3. Ortiz-Castro R., et al. Transkingdom signaling based on bacterial cyclodipeptides with auxin activity in plants. Proc. Natl Acad. Sci. U.S.A. 2011, 108:7253-7258.
4. Hughes D.T., Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat. Rev. Microbiol. 2008, 6:111-120.
5. Sperandio V., et al. Bacteria-host communication: the language of hormones. Proc. Natl Acad. Sci. U.S.A. 2003, 100:8951-8956.
6. Nealson K.H., Hastings J.W. Bacterial bioluminescence: its control and ecological significance. Microbiol. Rev. 1979, 43:496-518.
7. Moophayak K., et al. Evaluation of an I-box wind tunnel model for assessment of behavioral responses of blow flies. Parasitol. Res. 2013, 112:3789-3798.
8. O'Loughlin C.T., et al. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:17981-17986.
9. Lesic B., et al. Quorum sensing differentially regulates Pseudomonas aeruginosa type VI secretion locus I and homologous loci II and III, which are required for pathogenesis. Microbiology 2009, 155:2845-2855.
10. Chatterjee A., et al. Regulation of motility in Erwinia carotovora subsp. carotovora: quorum-sensing signal controls FlhDC, the global regulator of flagellar and exoprotein genes, by modulating the production of RsmA, an RNA-binding protein. Mol. Plant Microbe Interact. 2010, 23:1316-1323.
11. Lang J., Faure D. Functions and regulation of quorum-sensing in Agrobacterium tumefaciens. Front. Plant Sci. 2014, 5:14.
12. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
13. Chen R., et al. Dissection of quorum-sensing genes in Burkholderia glumae reveals non-canonical regulation and the new regulatory gene tofM for toxoflavin production. PLoS ONE 2012, 7:e52150.
14. Chen X., et al. Structural identification of a bacterial quorum-sensing signal containing boron. Nature 2002, 415:545-549.
15. Li J., et al. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3360-3365.
16. Trejo-Hernández A., et al. Interspecies competition triggers virulence and mutability in Candida albicans-Pseudomonas aeruginosa mixed biofilms. ISME J. 2014, 10.1038/ismej.2014.53.
17. Jacobi C.A. Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) - evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model. Gut Pathog. 2012, 4:8.
18. Higgins D.A., et al. The major Vibrio cholerae autoinducer and its role in virulence factor production. Nature 2007, 450:883-886.
19. Lerat E., Moran N.A. The evolutionary history of quorum-sensing systems in bacteria. Mol. Biol. Evol. 2004, 21:903-913.
20. Schuster M., et al. Acyl-homoserine lactone quorum sensing: from evolution to application. Annu. Rev. Microbiol. 2013, 67:43-63.
21. Tannières M., et al. A metagenomic study highlights phylogenetic proximity of quorum-quenching and xenobiotic-degrading amidases of the AS-family. PLoS ONE 2013, 8:e65473.
22. Pollitt E.J., et al. Cooperation, quorum sensing, and evolution of virulence in Staphylococcus aureus. Infect. Immun. 2014, 82:1045-1051.
23. West S.A., et al. Quorum sensing and the confusion about diffusion. Trends Microbiol. 2012, 20:586-594.
24. Cornforth D.M., et al. Combinatorial quorum sensing allows bacteria to resolve their social and physical environment. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:4280-4284.
25. González J.F., Venturi V. A novel widespread interkingdom signaling circuit. Trends Plant Sci. 2013, 18:167-174.
26. Prasad C. Bioactive cyclic dipeptides. Peptides 1995, 16:151-164.
27. Minelli A., et al. Focus on cyclo(His-Pro): history and perspectives as antioxidant peptide. Amino Acids 2008, 35:283-289.
28. Cornacchia C., et al. 2,5-Diketopiperazines as neuroprotective agents. Mini Rev. Med. Chem. 2012, 12:2-12.
29. Lahoud G., Hou Y.M. Biosynthesis: a new (old) way of hijacking tRNA. Nat. Chem. Biol. 2010, 6:795-796.
30. Kukla M.J., et al. Synthesis, characterization, and anorectic testing of the four stereoisomers of cyclo(histidylproline). J. Med. Chem. 1985, 28:1745-1747.
31. Beck J.G., et al. Intestinal permeability of cyclic peptides: common key backbone motifs identified. J. Am. Chem. Soc. 2012, 134:12125-12133.
32. Teixidó M., et al. Diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles. J. Am. Chem. Soc. 2007, 129:11802-11813.
33. de Carvalho M.P., Abraham W.R. Antimicrobial and biofilm inhibiting diketopiperazines. Curr. Med. Chem. 2012, 19:3564-3577.
34. Borthwick A.D. 2,5-Diketopiperazines: synthesis, reactions, medicinal chemistry, and bioactive natural products. Chem. Rev. 2012, 112:3641-3716.
35. Gu Q., et al. Identification and characterization of extracellular cyclic dipeptides as quorum-sensing signal molecules from Shewanella baltica, the specific spoilage organism of Pseudosciaena crocea during 4°C storage. J. Agric. Food Chem. 2013, 61:11645-11652.
36. Park D.K., et al. Cyclo(Phe-Pro) modulates the expression of ompU in Vibrio spp. J. Bacteriol. 2006, 188:2214-2221.
37. Vikram A., et al. Cyclo(valine-valine) inhibits Vibrio cholerae virulence gene expression. Microbiology 2014, 160:1054-1062.
38. Scopel M., et al. Dipeptide cis-cyclo(leucyl-tyrosyl) produced by sponge associated Penicillium sp. F37 inhibits biofilm formation of the pathogenic Staphylococcus epidermidis. Bioorg. Med. Chem. Lett. 2013, 23:624-626.
39. James G.A., et al. Biofilms in chronic wounds. Wound Repair Regen. 2008, 16:37-44.
40. Secor P.R., et al. Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression. PLoS ONE 2012, 7:e40973.
41. Gonzalez J.E., Keshavan N.D. Messing with bacterial quorum sensing. Microbiol. Mol. Biol. Rev. 2006, 70:859-875.
42. Borre Y.E., et al. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol. Med. 2014, 20:509-518.
43. De Palma G., et al. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?. J. Physiol. 2014, 592:2989-2997.
44. Holzer P., Farzi A. Neuropeptides and the microbiota-gut-brain axis. Adv. Exp. Med. Biol. 2014, 817:195-219.
45. Mann E.R., Li X. Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol. 2014, 20:9653-9664.
46. González H., et al. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. J. Neuroimmunol. 2014, 274:1-13.
47. Boiko S.S., et al. Regional and subcellular localization of cycloprolylglycine in rat brain. Bull. Exp. Biol. Med. 2010, 149:709-711.
48. Pelis R.M., Wright S.H. SLC22, SLC44, and SLC47 transporters - organic anion and cation transporters: molecular and cellular properties. Curr. Top. Membr. 2014, 73:233-261.
49. Taubert D., et al. Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons. PLoS ONE 2007, 2:e385.
50. Koepsell H. The SLC22 family with transporters of organic cations, anions and zwitterions. Mol. Aspects Med. 2013, 34:413-435.
51. Chung D.W., et al. Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. Cell. Mol. Neurobiol. 2010, 30:531-541.
52. Nakayama Y., et al. Molecular mechanisms of the LPS-induced non-apoptotic ER stress-CHOP pathway. J. Biochem. 2010, 147:471-483.
53. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
54. Bellezza I., et al. Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity. Int. J. Biochem. Cell Biol. 2014, 51:159-169.
55. Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia 2013, 61:71-90.
56. Brigelius-Flohe R., Flohé L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid. Redox Signal. 2011, 15:2335-2381.
57. Bellezza I. Nrf2 and NF-κB and their concerted modulation in cancer pathogenesis and progression. Cancers (Basel) 2010, 2:483-497.
58. Bellezza I., et al. Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity. J. Nutr. 2012, 23:1583-1591.
59. Bellezza I., et al. Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation. Mol. Immunol. 2013, 54:347-354.
60. Ganesh Yerra V., et al. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy. Redox Biol. 2013, 1:394-397.
61. Cuadrado A., et al. Transcription factors NRF2 and NF-κB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation. J. Biol. Chem. 2014, 289:15244-15258.
62. Leavy O. Inflammation: regulating ROS. Nat. Rev. Immunol. 2014, 14:357.
63. Minelli A., et al. Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signalling. J. Neurochem. 2009, 111:956-966.
64. Motterlini R., Foresti R. Heme oxygenase-1 as a target for drug discovery. Antioxid. Redox Signal. 2014, 20:1810-1826.
65. Koskenkorva-Frank T.S., et al. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic. Biol. Med. 2013, 65:1174-1194.
66. Mander P., Brown G.C. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J. Neuroinflammation 2005, 2:20.
67. Minelli A., et al. Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-κB and Nrf2 signalling. Int. J. Biochem. Cell Biol. 2012, 44:525-535.
68. Jadhav A., et al. Interaction among heme oxygenase, nuclear factor-kappaB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension 2008, 52:910-917.
69. Hosoi T., et al. Inhibition of inducible nitric oxide synthase and interleukin-1(expression by tunicamycin in cultured glial cells exposed to lipopolysaccharide. Brain Res. 2014, 1558:11-17.
70. Afrazi A., et al. Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J. Biol. Chem. 2014, 289:9584-9599.
71. Tam A.B., et al. ER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK. PLoS ONE 2012, 7:e45078.
72. Minelli A., et al. Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence. J. Cell. Mol. Med. 2009, 13:1149-1161.
73. Minelli A., et al. Phosphoproteomic analysis of the effect of cyclo-[His-Pro] dipeptide on PC12 cells. Peptides 2006, 27:105-113.
74. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
75. Lyman M., et al. Neuroinflammation: the role and consequences. Neurosci. Res. 2014, 79:1-12.
76. Perzborn M., et al. Enzymatical and microbial degradation of cyclic dipeptides (diketopiperazines). AMB Express 2013, 3:51.
77. Uyemura K., et al. Metabolism and toxicity of high doses of cyclo(His-Pro) plus zinc in healthy human subjects. J. Drug Metab. Toxicol. 2010, 1:105.
78. Kleinsmann A.J., Nachtsheim B.J. Phenylalanine-containing cyclic dipeptides - the lowest molecular weight hydrogelators based on unmodified proteinogenic amino acids. Chem. Commun. (Camb.) 2013, 49:7818-7820.